Workflow
嘉应制药(002198) - 2021 Q1 - 季度财报
002198JYPC(002198)2021-04-27 16:00

Financial Performance - The company's operating revenue for Q1 2021 was ¥121,970,257.25, representing a 32.02% increase compared to ¥92,384,827.51 in the same period last year[8] - Net profit attributable to shareholders for Q1 2021 was ¥7,764,389.66, a significant increase of 363.81% from ¥1,674,030.75 in the previous year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,755,443.98, up 205.29% from ¥2,540,317.24 year-on-year[8] - The basic earnings per share for Q1 2021 was ¥0.0153, which is a 363.64% increase compared to ¥0.0033 in the same period last year[8] - The weighted average return on equity for the reporting period was 1.13%, an increase of 0.88% from 0.25% in the previous year[8] - Operating revenue increased by CNY 29.585 million, a growth of 32.02%, driven by increased market demand following a decline in sales due to the pandemic last year[18] - Net profit increased by CNY 6.0904 million, a growth of 363.81%, attributed to increased sales revenue and decreased financial expenses[18] - Basic earnings per share increased by 363.81%, reflecting the growth in net profit[18] - The total operating revenue for Q1 2021 was CNY 121,970,257.25, an increase of 32.2% compared to CNY 92,384,827.51 in the same period last year[39] - The net profit for Q1 2021 was CNY 7,764,389.66, compared to CNY 1,674,030.75 in Q1 2020, representing a significant increase of 363.5%[40] - The total comprehensive income for the period was ¥740,407.74, a recovery from a loss of ¥898,960.27 in the same period last year[44] Cash Flow and Liquidity - The net cash flow from operating activities was -¥2,969,949.07, showing an improvement of 84.89% compared to -¥19,651,242.63 in the same period last year[8] - Cash flow from operating activities increased by CNY 16.6813 million, a growth of 84.49%, primarily due to increased cash received from sales and reduced cash payments for purchases[21] - The company's cash and cash equivalents decreased to CNY 19,723,433.09 from CNY 21,210,482.62, a decline of 7.0%[35] - The total cash and cash equivalents at the end of the period increased to ¥166,505,542.40 from ¥95,240,445.37 at the end of the same period last year[47] - The company's investment activities generated a net cash inflow of ¥32,229,612.31, a recovery from a net outflow of -¥894,872.43 in the previous year[46] - The company’s financing activities resulted in a net cash outflow of -¥4,990,618.71, compared to -¥6,522,436.95 in the previous year[47] - The net cash flow from financing activities was -CNY 4,990,618.71, indicating a decrease in cash from financing operations[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥800,963,760.16, a decrease of 0.92% from ¥808,439,808.13 at the end of the previous year[8] - The total assets as of March 31, 2021, amounted to CNY 497,701,703.64, slightly up from CNY 496,746,348.50 at the end of 2020[36] - The total liabilities as of March 31, 2021, were CNY 71,682,860.88, compared to CNY 71,467,913.48 at the end of 2020, indicating a marginal increase[36] - The inventory level decreased to CNY 34,474,494.23 from CNY 41,515,925.54, a reduction of 16.9%[35] - The total equity attributable to the parent company as of March 31, 2021, was CNY 690,770,430.72, compared to CNY 683,006,041.06 at the end of 2020, reflecting a growth of 1.1%[36] Shareholder Information - The company reported a total of 28,039 common shareholders at the end of the reporting period[11] - The top shareholder, Shenzhen Tiger Fund Management Co., Ltd., held 11.27% of the shares, amounting to 57,200,000 shares, which are currently pledged[11] Other Financial Metrics - Accounts receivable increased by CNY 19.589 million, a growth of 60.99%, mainly due to an increase in notes received from sales[18] - Other receivables decreased by CNY 25.1003 million, a decline of 73.73%, mainly due to the recovery of CNY 32.5 million from a debt[18] - Financial expenses decreased by CNY 1.5113 million, a decline of 129.21%, due to a reduction in total bank loans and interest expenses[18] - Income tax expenses increased by CNY 1.1908 million, a growth of 190.72%, due to an increase in total profit[18] - Sales expenses increased by CNY 25.7298 million, a growth of 68.96%, as last year's expenses were lower due to pandemic-related restrictions[18] Audit Status - The company has not undergone an audit for the Q1 2021 report, indicating that the figures are unaudited[51]